Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T J George

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
ESMO Open|March 5, 2025
Impact of tumor and node stages on the efficacy of adjuvant oxaliplatin-based chemotherapy in stage III colon cancer patients: an ACCENT pooled analysisR Cohen, M Raeisi, B Chibaudel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 8, 2016
Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classesJ H Chung, E Sanford, A Johnson, et al.
Medrxiv : the Preprint Server for Health Sciences|May 7, 2024
ALLIANCE A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancerJ Alvarez, Q Shi, A Dasari, et al.
ESMO Open|January 11, 2025
Nivolumab combination therapies in patients with advanced gastric and gastroesophageal junction cancer: the phase II FRACTION gastric cancer studyG Ku, G M Haag, H Park, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
ESMO Open|March 5, 2025
Impact of tumor and node stages on the efficacy of adjuvant oxaliplatin-based chemotherapy in stage III colon cancer patients: an ACCENT pooled analysisR Cohen, M Raeisi, B Chibaudel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 8, 2016
Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classesJ H Chung, E Sanford, A Johnson, et al.
Medrxiv : the Preprint Server for Health Sciences|May 7, 2024
ALLIANCE A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancerJ Alvarez, Q Shi, A Dasari, et al.
ESMO Open|January 11, 2025
Nivolumab combination therapies in patients with advanced gastric and gastroesophageal junction cancer: the phase II FRACTION gastric cancer studyG Ku, G M Haag, H Park, et al.
Pageof 2